ArticleFrontiers in oncology2025

Multi-cohort validation based on a novel prognostic signature of anoikis for predicting prognosis and immunotherapy response of esophageal squamous cell carcinoma.

Zhongquan Yi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.